16-15395988-G-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The ENST00000396385.4(MPV17L):āc.91G>Cā(p.Gly31Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00013 in 1,513,278 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00020 ( 0 hom., cov: 32)
Exomes š: 0.00012 ( 1 hom. )
Consequence
MPV17L
ENST00000396385.4 missense
ENST00000396385.4 missense
Scores
9
6
4
Clinical Significance
Conservation
PhyloP100: 7.04
Genes affected
MPV17L (HGNC:26827): (MPV17 mitochondrial inner membrane protein like) Involved in negative regulation of hydrogen peroxide biosynthetic process; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; and reactive oxygen species metabolic process. Located in peroxisome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.988
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPV17L | NM_001128423.2 | c.91G>C | p.Gly31Arg | missense_variant | 1/4 | ENST00000396385.4 | NP_001121895.1 | |
MPV17L-BMERB1 | NM_001414674.1 | c.91G>C | p.Gly31Arg | missense_variant | 1/6 | NP_001401603.1 | ||
MPV17L | NM_173803.4 | c.91G>C | p.Gly31Arg | missense_variant | 1/3 | NP_776164.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MPV17L | ENST00000396385.4 | c.91G>C | p.Gly31Arg | missense_variant | 1/4 | 1 | NM_001128423.2 | ENSP00000379669.3 | ||
ENSG00000261130 | ENST00000568766.1 | c.91G>C | p.Gly31Arg | missense_variant | 1/2 | 2 | ENSP00000454340.1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152178Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
31
AN:
152178
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000112 AC: 12AN: 107288Hom.: 1 AF XY: 0.000101 AC XY: 6AN XY: 59322
GnomAD3 exomes
AF:
AC:
12
AN:
107288
Hom.:
AF XY:
AC XY:
6
AN XY:
59322
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000121 AC: 165AN: 1360992Hom.: 1 Cov.: 31 AF XY: 0.000152 AC XY: 102AN XY: 670768
GnomAD4 exome
AF:
AC:
165
AN:
1360992
Hom.:
Cov.:
31
AF XY:
AC XY:
102
AN XY:
670768
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000204 AC: 31AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74454
GnomAD4 genome
AF:
AC:
31
AN:
152286
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 17, 2023 | The c.91G>C (p.G31R) alteration is located in exon 1 (coding exon 1) of the MPV17L gene. This alteration results from a G to C substitution at nucleotide position 91, causing the glycine (G) at amino acid position 31 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;M;.
MutationTaster
Benign
N;N
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
D;D;.
Vest4
MutPred
Gain of MoRF binding (P = 0.0287);Gain of MoRF binding (P = 0.0287);Gain of MoRF binding (P = 0.0287);
MVP
MPC
2.9
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at